1. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? 
Jeffrey Perl, Sharon J. Nessim, Joanne M. Bargman 
Kidney International 
Volume 79, Issue 8, Pages (April 2011)
DOI: /ki
Copyright © 2011 International Society of Nephrology Terms and Conditions

2. Figure 1
The GDP content among commercially available neutral pH, low-GDP peritoneal dialysis solutions (solutions 1–4) compared with the GDP content of conventional peritoneal dialysis solutions (solution 5). 3-DG, 3-deoxyglucosone; 3,4-DGE, 3,4-dideoxyglucosone-3-ene; 5-HMF, 5-hydroxymethyl furaldehyde; AcA, acetaldehyde; FoA, formaldehyde; GDP, glucose degradation product. *GDP concentrations for conventional peritoneal dialysis solutions (solution 5) were taken as an average from published values for Gambrosol, StaySafe, and Dianeal. All solutions are prepared using a commercially available 2.5% glucose concentration peritoneal dialysis solution. Total GDP content as measured by the summation of the individual glucose degradation products measured.
Adapted from Erixon M. et al.10
Kidney International  , DOI: ( /ki )
Copyright © 2011 International Society of Nephrology Terms and Conditions